These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 9816166

  • 1. Antibody engineering of recombinant Fv immunotoxins for improved targeting of cancer: disulfide-stabilized Fv immunotoxins.
    Reiter Y, Pastan I.
    Clin Cancer Res; 1996 Feb; 2(2):245-52. PubMed ID: 9816166
    [Abstract] [Full Text] [Related]

  • 2. Antitumor activity and pharmacokinetics in mice of a recombinant immunotoxin containing a disulfide-stabilized Fv fragment.
    Reiter Y, Pai LH, Brinkmann U, Wang QC, Pastan I.
    Cancer Res; 1994 May 15; 54(10):2714-8. PubMed ID: 8168102
    [Abstract] [Full Text] [Related]

  • 3. Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragments.
    Reiter Y, Brinkmann U, Lee B, Pastan I.
    Nat Biotechnol; 1996 Oct 15; 14(10):1239-45. PubMed ID: 9631086
    [Abstract] [Full Text] [Related]

  • 4. Engineering interchain disulfide bonds into conserved framework regions of Fv fragments: improved biochemical characteristics of recombinant immunotoxins containing disulfide-stabilized Fv.
    Reiter Y, Brinkmann U, Webber KO, Jung SH, Lee B, Pastan I.
    Protein Eng; 1994 May 15; 7(5):697-704. PubMed ID: 8073039
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxic and antitumor activity of a recombinant immunotoxin composed of disulfide-stabilized anti-Tac Fv fragment and truncated Pseudomonas exotoxin.
    Reiter Y, Kreitman RJ, Brinkmann U, Pastan I.
    Int J Cancer; 1994 Jul 01; 58(1):142-9. PubMed ID: 8014011
    [Abstract] [Full Text] [Related]

  • 6. Improved stability and yield of Fv targeted superantigen by introducing both linker and disulfide bond into the targeting moiety.
    Hao HJ, Jiang YQ, Zheng YL, Ma R, Yu DW.
    Biochimie; 2005 Aug 01; 87(8):661-7. PubMed ID: 15927340
    [Abstract] [Full Text] [Related]

  • 7. Disulfide stabilization of antibody Fv: computer predictions and experimental evaluation.
    Reiter Y, Brinkmann U, Jung SH, Pastan I, Lee B.
    Protein Eng; 1995 Dec 01; 8(12):1323-31. PubMed ID: 8869646
    [Abstract] [Full Text] [Related]

  • 8. Recombinant single-chain and disulfide-stabilized Fv-immunotoxins that cause complete regression of a human colon cancer xenograft in nude mice.
    Reiter Y, Wright AF, Tonge DW, Pastan I.
    Int J Cancer; 1996 Jul 03; 67(1):113-23. PubMed ID: 8690511
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Improved stability and yield of a Fv-toxin fusion protein by computer design and protein engineering of the Fv.
    Chowdhury PS, Vasmatzis G, Beers R, Lee B, Pastan I.
    J Mol Biol; 1998 Sep 04; 281(5):917-28. PubMed ID: 9719644
    [Abstract] [Full Text] [Related]

  • 12. Stabilization of a recombinant Fv fragment by base-loop interconnection and V(H)-V(L) permutation.
    Brinkmann U, Di Carlo A, Vasmatzis G, Kurochkina N, Beers R, Lee B, Pastan I.
    J Mol Biol; 1997 Apr 25; 268(1):107-17. PubMed ID: 9149145
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A recombinant immunotoxin containing a disulfide-stabilized Fv fragment.
    Brinkmann U, Reiter Y, Jung SH, Lee B, Pastan I.
    Proc Natl Acad Sci U S A; 1993 Aug 15; 90(16):7538-42. PubMed ID: 8356052
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Bivalent disulfide-stabilized fragment variable immunotoxin directed against mesotheliomas and ovarian cancer.
    Bera TK, Williams-Gould J, Beers R, Chowdhury P, Pastan I.
    Mol Cancer Ther; 2001 Dec 15; 1(2):79-84. PubMed ID: 12467225
    [Abstract] [Full Text] [Related]

  • 19. Characterization of B1(Fv)PE38 and B1(dsFv)PE38: single-chain and disulfide-stabilized Fv immunotoxins with increased activity that cause complete remissions of established human carcinoma xenografts in nude mice.
    Benhar I, Pastan I.
    Clin Cancer Res; 1995 Sep 15; 1(9):1023-9. PubMed ID: 9816075
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.